Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Exchange Rate Effect (2016 - 2025)

Amicus Therapeutics filings provide 10 years of Exchange Rate Effect readings, the most recent being -$329000.0 for Q4 2025.

  • On a quarterly basis, Exchange Rate Effect fell 110.59% to -$329000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $13.3 million, a 429.37% increase, with the full-year FY2025 number at $13.3 million, up 429.37% from a year prior.
  • Exchange Rate Effect hit -$329000.0 in Q4 2025 for Amicus Therapeutics, up from -$1.2 million in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $18.5 million in Q4 2022 to a low of -$20.7 million in Q3 2022.
  • Median Exchange Rate Effect over the past 5 years was -$1.0 million (2021), compared with a mean of -$205500.0.
  • Biggest five-year swings in Exchange Rate Effect: tumbled 3076.57% in 2022 and later surged 3496.94% in 2025.
  • Amicus Therapeutics' Exchange Rate Effect stood at -$908000.0 in 2021, then surged by 2137.56% to $18.5 million in 2022, then tumbled by 121.11% to -$3.9 million in 2023, then skyrocketed by 179.54% to $3.1 million in 2024, then plummeted by 110.59% to -$329000.0 in 2025.
  • The last three reported values for Exchange Rate Effect were -$329000.0 (Q4 2025), -$1.2 million (Q3 2025), and $10.0 million (Q2 2025) per Business Quant data.